149 related articles for article (PubMed ID: 3100950)
1. A Trypanosoma brucei mutant resistant to alpha-difluoromethylornithine.
Phillips MA; Wang CC
Mol Biochem Parasitol; 1987 Jan; 22(1):9-17. PubMed ID: 3100950
[TBL] [Abstract][Full Text] [Related]
2. Biochemical changes associated with alpha-difluoromethylornithine uptake and resistance in Trypanosoma brucei.
Bellofatto V; Fairlamb AH; Henderson GB; Cross GA
Mol Biochem Parasitol; 1987 Oct; 25(3):227-38. PubMed ID: 3122042
[TBL] [Abstract][Full Text] [Related]
3. Trypanosoma brucei brucei: characterization of an ODC null bloodstream form mutant and the action of alpha-difluoromethylornithine.
Li F; Hua SB; Wang CC; Gottesdiener KM
Exp Parasitol; 1998 Mar; 88(3):255-7. PubMed ID: 9562432
[TBL] [Abstract][Full Text] [Related]
4. Alpha-difluoromethylornithine resistance in Leishmania donovani is associated with increased ornithine decarboxylase activity.
Coons T; Hanson S; Bitonti AJ; McCann PP; Ullman B
Mol Biochem Parasitol; 1990 Feb; 39(1):77-89. PubMed ID: 2154691
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of DL-alpha-difluoromethylornithine against susceptible and drug-resistant Trypanosoma brucei brucei.
Zweygarth E; Kaminsky R
Acta Trop; 1991 Jan; 48(3):223-32. PubMed ID: 1671624
[TBL] [Abstract][Full Text] [Related]
6. Polyamine depletion following exposure to DL-alpha-difluoromethylornithine both in vivo and in vitro initiates morphological alterations and mitochondrial activation in a monomorphic strain of Trypanosoma brucei brucei.
Giffin BF; McCann PP; Bitonti AJ; Bacchi CJ
J Protozool; 1986 May; 33(2):238-43. PubMed ID: 3090240
[TBL] [Abstract][Full Text] [Related]
7. Effect of putrescine on the respiration of Trypanosoma brucei brucei.
Giffin BF; McCann PP; Bacchi CJ
Mol Biochem Parasitol; 1986 Aug; 20(2):165-71. PubMed ID: 3092047
[TBL] [Abstract][Full Text] [Related]
8. Further studies on difluoromethylornithine in African trypanosomes.
McCann PP; Bacchi CJ; Clarkson AB; Seed JR; Nathan HC; Amole BO; Hutner SH; Sjoerdsma A
Med Biol; 1981 Dec; 59(5-6):434-40. PubMed ID: 6175860
[TBL] [Abstract][Full Text] [Related]
9. Resistance to DL-alpha-difluoromethylornithine by clinical isolates of Trypanosoma brucei rhodesiense. Role of S-adenosylmethionine.
Bacchi CJ; Garofalo J; Ciminelli M; Rattendi D; Goldberg B; McCann PP; Yarlett N
Biochem Pharmacol; 1993 Aug; 46(3):471-81. PubMed ID: 8347171
[TBL] [Abstract][Full Text] [Related]
10. Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to D,L-alpha-difluoromethylornithine.
Iten M; Mett H; Evans A; Enyaru JC; Brun R; Kaminsky R
Antimicrob Agents Chemother; 1997 Sep; 41(9):1922-5. PubMed ID: 9303385
[TBL] [Abstract][Full Text] [Related]
11. In vivo effects of difluoromethylornithine on trypanothione and polyamine levels in bloodstream forms of Trypanosoma brucei.
Fairlamb AH; Henderson GB; Bacchi CJ; Cerami A
Mol Biochem Parasitol; 1987 Jun; 24(2):185-91. PubMed ID: 3114634
[TBL] [Abstract][Full Text] [Related]
12. X-ray structure of ornithine decarboxylase from Trypanosoma brucei: the native structure and the structure in complex with alpha-difluoromethylornithine.
Grishin NV; Osterman AL; Brooks HB; Phillips MA; Goldsmith EJ
Biochemistry; 1999 Nov; 38(46):15174-84. PubMed ID: 10563800
[TBL] [Abstract][Full Text] [Related]
13. Trypanosoma brucei ornithine decarboxylase: enzyme purification, characterization, and expression in Escherichia coli.
Phillips MA; Coffino P; Wang CC
J Biol Chem; 1988 Dec; 263(34):17933-41. PubMed ID: 3056933
[TBL] [Abstract][Full Text] [Related]
14. A Trypanosoma brucei bloodstream form mutant deficient in ornithine decarboxylase can protect against wild-type infection in mice.
Mutomba MC; Li F; Gottesdiener KM; Wang CC
Exp Parasitol; 1999 Feb; 91(2):176-84. PubMed ID: 9990346
[TBL] [Abstract][Full Text] [Related]
15. Effects of alpha-difluoromethylornithine on protein synthesis and synthesis of the variant-specific glycoprotein (VSG) in Trypanosoma brucei brucei.
Bitonti AJ; Cross-Doersen DE; McCann PP
Biochem J; 1988 Feb; 250(1):295-8. PubMed ID: 3128277
[TBL] [Abstract][Full Text] [Related]
16. Impairment of macrophage function by inhibitors of ornithine decarboxylase activity.
Kierszenbaum F; Wirth JJ; McCann PP; Sjoerdsma A
Infect Immun; 1987 Oct; 55(10):2461-4. PubMed ID: 3115898
[TBL] [Abstract][Full Text] [Related]
17. Trypanosoma brucei brucei: regulation of ornithine decarboxylase in procyclic forms and trypomastigotes.
Bacchi CJ; Garofalo J; Santana A; Hannan JC; Bitonti AJ; McCann PP
Exp Parasitol; 1989 May; 68(4):392-402. PubMed ID: 2498115
[TBL] [Abstract][Full Text] [Related]
18. Synergistic activity of 5-substituted 2-nitroimidazoles (Ro 15-0216 and benznidazole) and DL-alpha-difluoromethylornithine on Trypanosoma brucei brucei.
Zweygarth E; Kaminsky R; Sayer PD; van Nieuwenhove S
Ann Soc Belg Med Trop; 1990 Dec; 70(4):269-79. PubMed ID: 2291692
[TBL] [Abstract][Full Text] [Related]
19. Effects of the ornithine decarboxylase inhibitors DL-alpha-difluoromethylornithine and alpha-monofluoromethyldehydroornithine methyl ester alone and in combination with suramin against Trypanosoma brucei brucei central nervous system models.
Bacchi CJ; Nathan HC; Clarkson AB; Bienen EJ; Bitonti AJ; McCann PP; Sjoerdsma A
Am J Trop Med Hyg; 1987 Jan; 36(1):46-52. PubMed ID: 3101528
[TBL] [Abstract][Full Text] [Related]
20. [DFMO: an alternative therapeutic agent for human African trypanosomiasis].
Breton JC; Bouteille B; Sonan T
Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):571-7. PubMed ID: 3143490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
